Biovision Ventures is a venture capital firm investing in early-stage therapeutics and digital health opportunities primarily in the US and Europe. The firm focuses on innovative life sciences companies that aim to translate scientific advancements into transformative therapies.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Biovision Ventures is a venture capital firm focused on life sciences and healthcare, based in Paphos, Cyprus, with a presence in Berlin, Germany. The organization supports innovative early-stage companies that aim to translate scientific advancements into transformative therapies. Biovision Ventures invests in therapeutics and Bio-IT, prioritizing companies developing novel platform-based therapeutic approaches with strong intellectual property protection. The firm typically invests from Series Seed to Series B, often leading or co-leading investments and maintaining an active role in portfolio companies.
The firm invests primarily in therapeutics and Bio-IT, focusing on platform-based therapeutic approaches and medical software solutions for clinical use. Biovision Ventures is agnostic regarding specific diseases and modalities, allowing for a broad investment scope within the life sciences sector.
Biovision Ventures adds value to its portfolio companies by actively participating in their growth, often taking board seats and leveraging its expertise to guide them towards early value inflection points.
Biovision Ventures focuses on early-stage life sciences and healthcare companies, particularly those developing therapeutics and Bio-IT solutions. The firm prioritizes companies with strong intellectual property and those addressing unmet clinical needs.
Founders can pitch their ideas through the firm's website at biovision.vc. It is advisable to include a detailed business plan and information about the team and technology.
Biovision Ventures distinguishes itself by its focus on early-stage investments in the life sciences sector and its hands-on approach to supporting portfolio companies, often taking board seats to guide them through critical growth phases.
The firm primarily invests in private companies located in North America and Europe, aiming to identify global technological leaders regardless of their location.
Biovision Ventures typically invests between EUR 1.5 million and EUR 3 million in its portfolio companies, focusing on early-stage funding rounds.
The firm maintains an active role in its portfolio companies, often taking board positions to provide strategic guidance and support as they work towards early value inflection points.
Organizations that do similar work to Biovision Ventures.
InvestorSV Health Investors is a healthcare-focused venture capital and growth equity firm based in Boston and London. With over 30 years of experience, it specializes in investing across various healthcare sectors, including biotechnology and medtech.
InvestorDeerfield Management is a New York City-based investment management firm specializing in healthcare investments, managing over $15 billion in assets across more than 200 companies. The firm focuses on both public and private investments in sectors such as biotechnology, medical devices, and digital health.
InvestorHuman Capital is a multi-stage venture capital firm that partners with exceptional founders to build companies addressing critical industry challenges. They focus on assembling high-caliber teams and deploying capital to support these ventures.
InvestorNueterra Capital is a Midwest-based venture capital firm that invests in early-stage healthcare and technology companies. Founded in 1997, it focuses on innovative firms in U.S. Emerging Markets.
Superscout Pro
Is this page right?Reviewed · How the research works